85 related articles for article (PubMed ID: 15164564)
21. Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer.
Wang MZ; Li LY; Wang SL; Zhang XT; Zhong W; Zhang L
Chin Med J (Engl); 2006 Jan; 119(1):63-8. PubMed ID: 16454984
[No Abstract] [Full Text] [Related]
22. Implications of the Iressa Survival Evaluation in Lung Cancer trial and the future of gefitinib.
Belani CP; Ramalingam S
Clin Lung Cancer; 2005 Jan; 6(4):203-4. PubMed ID: 15694010
[No Abstract] [Full Text] [Related]
23. Improvements in quality of life and disease-related symptoms in patients with advanced non-small cell lung cancer treated with gefitinib.
Zhang XT; Li LY; Wang SL; Mu XL; Wang MZ; Song W
Chin Med J (Engl); 2005 Oct; 118(19):1661-4. PubMed ID: 16232354
[No Abstract] [Full Text] [Related]
24. Clinical responses to gefinitib after failure of treatment with cetuximab in advanced non-small-cell lung cancer.
Raez LE; Lopes G; Lilenbaum R
J Clin Oncol; 2005 Jun; 23(18):4244-5. PubMed ID: 15961783
[No Abstract] [Full Text] [Related]
25. [Non-small cell lung cancer: 1) Molecular-target therapy].
Muguruma H; Yano S; Sone S
Nihon Naika Gakkai Zasshi; 2003 Jul; 92(7):1284-90. PubMed ID: 12924275
[No Abstract] [Full Text] [Related]
26. Biomarkers of response to gefitinib in non-small-cell lung cancer.
Carbone DP
Nat Clin Pract Oncol; 2004 Dec; 1(2):66-7. PubMed ID: 16264818
[No Abstract] [Full Text] [Related]
27. Gefitinib in patients with non-small cell lung cancer: symptomatic improvement within a few days.
Bearz A; Vaccher E; Spazzapan S; Berretta M; Tirelli U
Lung Cancer; 2005 Sep; 49(3):417-8. PubMed ID: 16102608
[No Abstract] [Full Text] [Related]
28. Medicine. Why a new cancer drug works well, in some patients.
Marx J
Science; 2004 Apr; 304(5671):658-9. PubMed ID: 15118127
[No Abstract] [Full Text] [Related]
29. Gefitinib.
Muhsin M; Graham J; Kirkpatrick P
Nat Rev Drug Discov; 2003 Jul; 2(7):515-6. PubMed ID: 12841190
[No Abstract] [Full Text] [Related]
30. [Maintenance treatment of non-small cell lung cancer].
Hansen O; Schytte T
Ugeskr Laeger; 2010 Mar; 172(12):954. PubMed ID: 20334788
[No Abstract] [Full Text] [Related]
31. Promising new treatment schedule for gefitinib responders after severe hepatotoxicity with daily administration.
Seki N; Uematsu K; Shibakuki R; Eguchi K
J Clin Oncol; 2006 Jul; 24(19):3213-4; author reply 3214-5. PubMed ID: 16809744
[No Abstract] [Full Text] [Related]
32. Gefitinib for advanced or metastatic non-small cell lung cancer.
Perras C
Issues Emerg Health Technol; 2004 Apr; (55):1-4. PubMed ID: 15085875
[TBL] [Abstract][Full Text] [Related]
33. APL during gefitinib treatment for non-small-cell lung cancer.
Uchida A; Matsuo K; Tanimoto M
N Engl J Med; 2005 Feb; 352(8):843. PubMed ID: 15728826
[No Abstract] [Full Text] [Related]
34. [Is it possible to treat bronchial carcinoma without chemotherapy?].
Pujol JL
Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S23-10S26. PubMed ID: 17127957
[No Abstract] [Full Text] [Related]
35. Non-small-cell lung cancer patients unsuitable for first-line chemotherapy: a new category of patients for clinical studies?
Soto Parra HJ; Latteri F; Cavina R; De Vincenzo F; Zucali PA; Campagnoli E; Santoro A
J Am Geriatr Soc; 2005 Jun; 53(6):1078-80. PubMed ID: 15935045
[No Abstract] [Full Text] [Related]
36. Lack of response to erlotinib after progression on gefitinib in patients with advanced non-small cell lung cancer.
Viswanathan A; Pillot G; Govindan R
Lung Cancer; 2005 Dec; 50(3):417-8. PubMed ID: 16129510
[No Abstract] [Full Text] [Related]
37. Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer.
Pitini V; Arrigo C; Altavilla G
J Clin Oncol; 2008 Jul; 26(21):3645-6. PubMed ID: 18640945
[No Abstract] [Full Text] [Related]
38. [A new medication for lung cancer].
Krankenpfl J; 2005; 43(7-10):227. PubMed ID: 16515296
[No Abstract] [Full Text] [Related]
39. More haste, less speed.
Lancet Oncol; 2003 Jun; 4(6):325. PubMed ID: 12788389
[No Abstract] [Full Text] [Related]
40. Icotinib: kick-starting the Chinese anticancer drug industry.
Camidge DR
Lancet Oncol; 2013 Sep; 14(10):913-4. PubMed ID: 23948350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
